Cargando…

Use of Proton-Pump Inhibitors Predicts Heart Failure and Death in Patients with Coronary Artery Disease

OBJECTIVES: Proton-pump inhibitors (PPIs) seem to increase the incidence of cardiovascular events in patients with coronary artery disease (CAD), mainly in those using clopidogrel. We analysed the impact of PPIs on the prognosis of patients with stable CAD. METHODS: We followed 706 patients with CAD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pello Lázaro, Ana María, Cristóbal, Carmen, Franco-Peláez, Juan Antonio, Tarín, Nieves, Aceña, Álvaro, Carda, Rocío, Huelmos, Ana, Martín-Mariscal, María Luisa, Fuentes-Antras, Jesús, Martínez-Millá, Juan, Alonso, Joaquín, Lorenzo, Óscar, Egido, Jesús, López-Bescós, Lorenzo, Tuñón, José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5245803/ https://www.ncbi.nlm.nih.gov/pubmed/28103324 http://dx.doi.org/10.1371/journal.pone.0169826

Ejemplares similares

Coexistence of Low Vitamin D and High Fibroblast Growth Factor-23 Plasma Levels Predicts an Adverse Outcome in Patients with Coronary Artery Disease
por: Tuñón, José, et al.
Publicado: (2014)

N-Terminal Pro-Brain Natriuretic Peptide Is Associated with a Future Diagnosis of Cancer in Patients with Coronary Artery Disease
por: Tuñón, José, et al.
Publicado: (2015)

N-Terminal Pro-Brain Natriuretic Peptide Plasma Levels Are Associated with Intermediate-Term Follow-Up Cancer in Coronary Patients
por: Tuñón, José, et al.
Publicado: (2021)

MCP-1 Predicts Recurrent Cardiovascular Events in Patients with Persistent Inflammation
por: Blanco-Colio, Luis M., et al.
Publicado: (2021)

Absence of High Lipoprotein(a) Levels Is an Independent Predictor of Acute Myocardial Infarction without Coronary Lesions
por: Kallmeyer, Andrea, et al.
Publicado: (2023)

Galectin-3 is Associated with Cardiovascular Events in Post-Acute Coronary Syndrome Patients with Type-2 Diabetes
por: Lorenzo-Almorós, Ana, et al.
Publicado: (2020)

NT-proBNP Levels Influence the Prognostic Value of Mineral Metabolism Biomarkers in Coronary Artery Disease
por: Martínez-Milla, Juan, et al.
Publicado: (2022)

Parathormone levels add prognostic ability to N‐terminal pro‐brain natriuretic peptide in stable coronary patients
por: Gutiérrez‐Landaluce, Carlos, et al.
Publicado: (2021)

Monocyte Chemoattractant Protein-1 Is an Independent Predictor of Coronary Artery Ectasia in Patients with Acute Coronary Syndrome
por: Franco-Peláez, Juan Antonio, et al.
Publicado: (2020)

Plasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery Disease
por: Martín-Reyes, Roberto, et al.
Publicado: (2016)

Prognostic value of initial QRS analysis in anterior STEMI: Correlation with left ventricular systolic dysfunction, serum biomarkers, and cardiac outcomes
por: López‐Castillo, Marta, et al.
Publicado: (2020)

Targeting metabolic disturbance in the diabetic heart
por: Fuentes-Antrás, Jesús, et al.
Publicado: (2015)

Cardiovascular Damage in COVID-19: Therapeutic Approaches Targeting the Renin-Angiotensin-Aldosterone System
por: Lumpuy-Castillo, Jairo, et al.
Publicado: (2020)

Activation of Toll-Like Receptors and Inflammasome Complexes in the Diabetic Cardiomyopathy-Associated Inflammation
por: Fuentes-Antrás, J., et al.
Publicado: (2014)

Design and rationale of a multicentre, randomised, double-blind, placebo-controlled clinical trial to evaluate the effect of vitamin D on ventricular remodelling in patients with anterior myocardial infarction: the VITamin D in Acute Myocardial Infarction (VITDAMI) trial
por: Tuñón, José, et al.
Publicado: (2016)

Updating Experimental Models of Diabetic Cardiomyopathy
por: Fuentes-Antrás, J., et al.
Publicado: (2015)

Anti-Inflammatory Drugs in Patients with Ischemic Heart Disease
por: Pello Lázaro, Ana María, et al.
Publicado: (2021)

Common pathways of hypercholesterolemia and hypertension leading to atherothrombosis: the need for a global approach in the management of cardiovascular risk factors
por: Tuñón, José, et al.
Publicado: (2007)

Statin use is associated with reduced mortality after respiratory viral infection
por: Franco-Peláez, Juan Antonio, et al.
Publicado: (2021)

The role of bioimpedance analysis in overweight and obese patients with acute heart failure: a pilot study
por: Venegas‐Rodríguez, Ana, et al.
Publicado: (2023)

Prevalence and prognostic value of monoclonal gammopathy in heart failure patients with preserved ejection fraction: A prospective study
por: Devesa, Ana, et al.
Publicado: (2022)

Prevalence of transthyretin amyloidosis in patients with heart failure and no left ventricular hypertrophy
por: Devesa, Ana, et al.
Publicado: (2021)

Correction: Sitagliptin Reduces Cardiac Apoptosis, Hypertrophy and Fibrosis Primarily by Insulin-Dependent Mechanisms in Experimental type-II Diabetes. Potential Roles of GLP-1 Isoforms
por: Picatoste, Belén, et al.
Publicado: (2013)

Sitagliptin Reduces Cardiac Apoptosis, Hypertrophy and Fibrosis Primarily by Insulin-Dependent Mechanisms in Experimental type-II Diabetes. Potential Roles of GLP-1 Isoforms
por: Picatoste, Belén, et al.
Publicado: (2013)

Potential Role of the mTORC1-PGC1α-PPARα Axis under Type-II Diabetes and Hypertension in the Human Heart
por: Hang, Tianyu, et al.
Publicado: (2023)

Takotsubo syndrome after mitral valve surgery: a case report
por: Devesa, Ana, et al.
Publicado: (2020)

Beta-blocker therapy in elderly patients with renal dysfunction and heart failure
por: Martínez-Milla, Juan, et al.
Publicado: (2021)

Alteration of Energy Substrates and ROS Production in Diabetic Cardiomyopathy
por: Lorenzo, O., et al.
Publicado: (2013)

Diagnostic approaches for diabetic cardiomyopathy
por: Lorenzo-Almorós, A., et al.
Publicado: (2017)

Calcium channel blockers and beta-blockers could increased mortality of patients with COVID-19
por: Esteban-Lucia, L, et al.
Publicado: (2021)

Predictive and diagnostic biomarkers for gestational diabetes and its associated metabolic and cardiovascular diseases
por: Lorenzo-Almorós, A., et al.
Publicado: (2019)

Potential Role of Nuclear Factor κB in Diabetic Cardiomyopathy
por: Lorenzo, O., et al.
Publicado: (2011)

Severe Acute Hepatitis of Unknown Origin in Children: What Do We Know Today?
por: Pérez-Gracia, María Teresa, et al.
Publicado: (2022)

Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes
por: Ramírez, Elisa, et al.
Publicado: (2013)

Competencias esenciales en la formación de los residentes, ¿qué nos ha enseñado la pandemia por la COVID-19?
por: Anglada, María Isabel González, et al.
Publicado: (2022)

Ubiquitous Virtual Private Network: A Solution for WSN Seamless Integration
por: Villa, David, et al.
Publicado: (2014)

Dapagliflozin Improved Cardiac Function and Structure in Diabetic Patients with Preserved Ejection Fraction: Results of a Single Centre, Observational Prospective Study
por: Cortés, Marcelino, et al.
Publicado: (2023)

Prognostic Value of Lymphocyte-Activation Gene 3 (LAG3) in Cancer: A Meta-Analysis
por: Saleh, Ramy R., et al.
Publicado: (2019)

Association between Psychopathological Dimensions and Sexual Functioning/Sexual Arousal in Young Adults
por: Soler, Franklin, et al.
Publicado: (2021)

Clinical, Biochemical, and Molecular Characterization of Two Families with Novel Mutations in the LDHA Gene (GSD XI)
por: Serrano-Lorenzo, Pablo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d9kus8vnb5lhisckou9buntlis